Sideroblastic anemia following treatment of chronic myeloid leukemia with busulfan

@article{Magalhaes2000SideroblasticAF,
  title={Sideroblastic anemia following treatment of chronic myeloid leukemia with busulfan},
  author={Smm Magalhaes and F R Duarte and SCC Ribeiro and C L Borovik and Irene GH Lorand-Metze},
  journal={Leukemia},
  year={2000},
  volume={14},
  pages={214-215}
}
BNML/P, parental BNML cell line; BNML/Dauno-R, daunomycineresistant BNML subline; BNML/Ara-C-R, cytosine arabinosideresistant BNML subline; BNML/CP-R, cyclophosphamide-resistant BNML subline. aIST increase in (median) survival time of treated rats vs control group. bLCK, log cell kill. The value is deduced from the known linear relationship between leukemic… CONTINUE READING